Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Payables (2020 - 2025)

Historic Payables for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to $6.1 million.

  • SOPHiA GENETICS's Payables rose 318.62% to $6.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.1 million, marking a year-over-year increase of 318.62%. This contributed to the annual value of $5.2 million for FY2024, which is 317.2% down from last year.
  • Per SOPHiA GENETICS's latest filing, its Payables stood at $6.1 million for Q3 2025, which was up 318.62% from $7.7 million recorded in Q2 2025.
  • SOPHiA GENETICS's Payables' 5-year high stood at $8.8 million during Q3 2021, with a 5-year trough of $4.6 million in Q1 2025.
  • In the last 5 years, SOPHiA GENETICS's Payables had a median value of $6.2 million in 2022 and averaged $6.4 million.
  • In the last 5 years, SOPHiA GENETICS's Payables crashed by 3592.88% in 2022 and then skyrocketed by 4532.98% in 2025.
  • SOPHiA GENETICS's Payables (Quarter) stood at $6.7 million in 2021, then decreased by 8.25% to $6.2 million in 2022, then decreased by 12.78% to $5.4 million in 2023, then decreased by 3.17% to $5.2 million in 2024, then rose by 16.02% to $6.1 million in 2025.
  • Its Payables was $6.1 million in Q3 2025, compared to $7.7 million in Q2 2025 and $4.6 million in Q1 2025.